These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8769220)

  • 1. Uses of Neoral in pediatric liver transplantation.
    McDiarmid SV
    Transplant Proc; 1996 Aug; 28(4):2264-6. PubMed ID: 8769220
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption.
    Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R
    Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
    Grant D; Rochon J; Levy G
    Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential role of Neoral in pediatric liver transplantation.
    Whitington PF; Alonso EM; Millis JM
    Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
    [No Abstract]   [Full Text] [Related]  

  • 7. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
    Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
    Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
    Hoyer PF; Boekenkamp A; Vester U; Offner G; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Neoral in pediatric renal transplantation.
    Ettenger RE; Smith HT; Kaiser B; Cooney GF; Summerauer J; Alexander S; Moulton LT; Choc MG; Wong RL
    Transplant Proc; 1996 Aug; 28(4):2257-8. PubMed ID: 8769217
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
    Cooney GF; Lum BL; Meligeni JA; Dunn SP
    Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG; Lodge JP
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoral in liver transplantation.
    Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
    Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program.
    Mueller EA; Kovarik JM; Pittrow D
    Transplant Proc; 1998 Aug; 30(5):1691-3. PubMed ID: 9723246
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.
    Paradis K; al Edreesi M; St-Vil D; Laberge JM; Dupuis C; Rasquin-Weber A
    Transplant Proc; 1994 Oct; 26(5):2777-8. PubMed ID: 7940875
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
    Fisher RA; Pan SH; Rossi SJ; Schroeder TJ; Irish WD; Canafax DM; Lopez RR
    Transplant Proc; 1999; 31(1-2):394-5. PubMed ID: 10083157
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine pharmacology.
    Lee JI; Canafax DM
    Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
    Serafinowicz A; Gaciong Z; Baçzkowska T; Rell K; Lao M; Wałaszewski J
    Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoral in liver transplantation.
    Levy GA; Grant D
    Transplant Proc; 1996 Apr; 28(2):1019-21. PubMed ID: 8623216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.